Chemical Approaches to Define the Structure-Activity Relationship of Heparin-like Glycosaminoglycans

Gallagher, 1992, Heparan-sulfate in the binding and activation of basic fibroblast growth-factor, Glycobiology, 2, 523, 10.1093/glycob/2.6.523

Spillmann, 1994, Glycosaminoglycan protein interactions: a question of specificity, Curr. Opin. Struct. Biol., 4, 677, 10.1016/S0959-440X(94)90165-1

Rostand, 1997, Microbial adherence to and invasion through proteoglycans, Infect. Immun., 65, 1, 10.1128/IAI.65.1.1-8.1997

Capila, 2002, Heparin-protein interactions, Angew. Chem. Int. Ed. Engl., 41, 391, 10.1002/1521-3773(20020201)41:3<390::AID-ANIE390>3.0.CO;2-B

Esko, 2002, Order out of chaos: assembly of ligand binding sites in heparan sulfate, Annu. Rev. Biochem., 71, 435, 10.1146/annurev.biochem.71.110601.135458

Engelberg, 1984, Heparin and the atherosclerotic process, Pharmacol. Rev., 36, 91

Chong, 1992, Heparin-induced thrombocytopenia, Aust. N. Z. J. Med., 22, 145, 10.1111/j.1445-5994.1992.tb02796.x

Gavard, 2003, Efficient preparation of three building blocks for the synthesis of heparan sulfate fragments: towards the combinatorial synthesis of oligosaccharides from hypervariable regions, Eur. J. Org. Chem., 2003, 3603, 10.1002/ejoc.200300254

Gallagher, 1985, Molecular distinctions between heparan-sulfate and heparin. Analysis of sulfation patterns indicates that heparan-sulfate and heparin are separate families of N-sulfated polysaccharides, Biochem. J., 230, 665, 10.1042/bj2300665

van Boeckel, 1993, The unique antithrombin-III binding domain of Heparin: a lead to new synthetic antithrombotics, Angew. Chem. Int. Ed. Engl., 32, 1671, 10.1002/anie.199316713

Petitou, 2004, A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next?, Angew. Chem. Int. Ed. Engl., 43, 3118, 10.1002/anie.200300640

Poletti, 2003, Chemical contributions to understanding heparin activity: synthesis of related sulfated oligosaccharides, Eur. J. Org. Chem., 2003, 2999, 10.1002/ejoc.200200721

Codee, 2004, The synthesis of well-defined heparin and heparan sulfate fragments, Drug Discov. Today: Technol., 1, 317, 10.1016/j.ddtec.2004.11.017

Powell, 2004, Interactions of heparin/heparan sulfate with proteins: appraisal of structural factors and experimental approaches, Glycobiology, 14, 17R, 10.1093/glycob/cwh051

Rabenstein, 2002, Heparin and heparan sulfate: structure and function, Nat. Prod. Rep., 19, 312, 10.1039/b100916h

Lindahl, 1986, Biosynthesis of heparin, Trends Biochem. Sci., 11, 221, 10.1016/0968-0004(86)90011-3

McCormick, 2000, The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate, Proc. Natl. Acad. Sci. USA, 97, 668, 10.1073/pnas.97.2.668

Lidholt, 1992, The D-glucuronosyl-transferase and N-acetyl-D- glucosaminyltransferase reactions and their relation to polymer modification, Biochem. J., 287, 21, 10.1042/bj2870021

Mulloy, 1993, NMR and molecular-modeling studies of the solution conformation of heparin, Biochem. J., 293, 849, 10.1042/bj2930849

Mulloy, 2001, Order out of complexity—protein structures that interact with heparin, Curr. Opin. Struct. Biol., 11, 623, 10.1016/S0959-440X(00)00257-8

Hricovini, 2001, Conformation of heparin pentasaccharide bound to antithrombin III, Biochem. J., 359, 265, 10.1042/0264-6021:3590265

Mulloy, 2000, Conformation and dynamics of heparin and heparan sulfate, Glycobiology, 10, 1147, 10.1093/glycob/10.11.1147

Casu, 1986, Controversial glycosamino-glycan conformations, Nature, 322, 215, 10.1038/322215b0

Ferro, 1986, Evidence for conformational equilibrium of the sulfated L-iduronate residue in heparin and in synthetic heparin monosaccharides and oligosaccharides: NMR and force-field studies, J. Am. Chem. Soc., 108, 6773, 10.1021/ja00281a052

Gatti, 1979, Studies on the conformation of heparin by H-1 and C-13 NMR- spectroscopy, Macromolecules, 12, 1001, 10.1021/ma60071a044

Yates, 1996, H-1 and C-13 NMR spectral assignments of the major sequences of twelve systematically modified heparin derivatives, Carbohydr. Res., 294, 15, 10.1016/S0008-6215(96)00213-3

Hileman, 1998, Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins, Bioessays, 20, 156, 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.0.CO;2-R

Raman, 2003, Structural specificity of heparin binding in the fibroblast growth factor family of proteins, Proc. Natl. Acad. Sci. USA, 100, 2357, 10.1073/pnas.0437842100

Raman, 2005, Structural insights into biological roles of protein-glycosaminoglycan interactions, Chem. Biol., 12, 267, 10.1016/j.chembiol.2004.11.020

Pellegrini, 2000, Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin, Nature, 407, 1029, 10.1038/35039551

Faham, 1996, Heparin structure and interactions with basic fibroblast growth factor, Science, 271, 1116, 10.1126/science.271.5252.1116

Kjellen, 1991, Proteoglycans: structures and interactions, Annu. Rev. Biochem., 60, 443, 10.1146/annurev.bi.60.070191.002303

Kan, 1993, An essential heparin-binding domain in the fibroblast growth-factor receptor kinase, Science, 259, 1918, 10.1126/science.8456318

Mach, 1993, Nature of the interaction of heparin with acidic fibroblast growth-factor, Biochemistry, 32, 5480, 10.1021/bi00071a026

Thompson, 1994, Energetic characterization of the basic fibroblast growth-factor heparin interaction: identification of the heparin-binding domain, Biochemistry, 33, 3831, 10.1021/bi00179a006

Maccarana, 1994, Minimal sequence in heparin heparan-sulfate required for binding of basic fibroblast growth-factor, J. Biol. Chem., 269, 3903, 10.1016/S0021-9258(17)41946-6

Ornitz, 1995, FGF binding and FGF receptor activation by synthetic heparan-derived disaccharides and trisaccharides, Science, 268, 432, 10.1126/science.7536345

Herr, 1997, Heparin-induced self-association of fibroblast growth factor-2. Evidence for two oligomerization processes, J. Biol. Chem., 272, 16382, 10.1074/jbc.272.26.16382

Pellegrini, 2001, Role of heparan sulfate in fibroblast growth factor signalling: a structural view, Curr. Opin. Struct. Biol., 11, 629, 10.1016/S0959-440X(00)00258-X

Guerrini, 2002, Minimal heparin/heparan sulfate sequences for binding to fibroblast growth factor-1, Biochem. Biophys. Res. Commun., 292, 222, 10.1006/bbrc.2002.6634

Maccarana, 1993, Minimal sequence in heparin heparan-sulfate required for binding of basic fibroblast growth-factor, J. Biol. Chem., 268, 23898, 10.1016/S0021-9258(20)80470-0

Guimond, 1993, Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4, J. Biol. Chem., 268, 23906, 10.1016/S0021-9258(20)80471-2

DiGabriele, 1998, Structure of a heparin-linked biologically active dimer of fibroblast growth factor, Nature, 393, 812, 10.1038/31741

Turnbull, 1992, Identification of the basic fibroblast growth-factor binding sequence in fibroblast heparan-sulfate, J. Biol. Chem., 267, 10337, 10.1016/S0021-9258(19)50023-0

Walker, 1994, Specific heparan-sulfate saccharides mediate the activity of basic fibroblast growth-factor, J. Biol. Chem., 269, 931, 10.1016/S0021-9258(17)42201-0

Rusnati, 1994, Distinct role of 2-O-sulfate, N-sulfate, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth-factor and soluble FGF receptor-1, Biochem. Biophys. Res. Commun., 203, 450, 10.1006/bbrc.1994.2203

Wang, 1997, Glycosaminoglycans can influence fibroblast growth factor-2 mitogenicity without significant growth factor binding, Biochem. Biophys. Res. Commun., 235, 369, 10.1006/bbrc.1997.6789

Petitou, 1997, Synthesis and pharmacological properties of a close analogue of an antithrombotic pentasaccharide (SR 90107A ORG 31540), J. Med. Chem., 40, 1600, 10.1021/jm960726z

Koshida, 1999, Synthesis of heparin partial structures and their binding activities to platelets, Bioorg. Med. Chem. Lett., 9, 3127, 10.1016/S0960-894X(99)00550-8

Iacomini, 1999, “Linkage region” sequences of heparins and heparan sulfates: detection and quantification by nuclear magnetic resonance spectroscopy, Anal. Biochem., 274, 50, 10.1006/abio.1999.4230

Schlessinger, 2000, Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization, Mol. Cell, 6, 743, 10.1016/S1097-2765(00)00073-3

Jin, 1997, The anticoagulant activation of antithrombin by heparin, Proc. Natl. Acad. Sci. USA, 94, 14683, 10.1073/pnas.94.26.14683

Casu, 1981, The structure of heparin oligosaccharide fragments with high anti-(factor-Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studies, Biochem. J., 197, 599, 10.1042/bj1970599

Atha, 1985, Contribution of monosaccharide residues in heparin binding to antithrombin-III, Biochemistry, 24, 6723, 10.1021/bi00344a063

Lindahl, 1983, The antithrombin-binding sequence in heparin. Identification of an essential 6-O-sulfate group, J. Biol. Chem., 258, 9826, 10.1016/S0021-9258(17)44572-8

Riesenfeld, 1981, The antithrombin-binding sequence of heparin. Location of essential N-sulfate groups, J. Biol. Chem., 256, 2389, 10.1016/S0021-9258(19)69792-9

Beetz, 1986, Synthesis of an antithrombin binding heparin-like pentasaccharide lacking 6-O sulfate at its reducing end, Tetrahedron Lett., 27, 5889, 10.1016/S0040-4039(00)85356-3

Li, 2004, Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin, Nat. Struct. Mol. Biol., 11, 857, 10.1038/nsmb811

Dementiev, 2004, The ternary complex of antithrombin-anhydrothrombin heparin reveals the basis of inhibitor specificity, Nat. Struct. Mol. Biol., 11, 863, 10.1038/nsmb810

van Boeckel, 1995, Glycosaminoglycans: synthetic fragments and their interaction with serine-protease inhibitors, Pure Appl. Chem., 67, 1663, 10.1351/pac199567101663

Grootenhuis, 1995, Rational design of synthetic heparin analogs with tailor-made coagulation-factor inhibitory activity, Nat. Struct. Biol., 2, 736, 10.1038/nsb0995-736

Petitou, 1999, Synthesis of thrombin-inhibiting heparin mimetics without side effects, Nature, 398, 417, 10.1038/18877

Kelton, 2002, Heparin-induced thrombocytopenia: an overview, Blood Rev., 16, 77, 10.1054/blre.2001.0189

Muller, 2001, Involvement of chemokine receptors in breast cancer metastasis, Nature, 410, 50, 10.1038/35065016

Ibel, 1986, Low-resolution structure of the complex of human blood platelet factor 4 with heparin determined by small-angle neutron scattering, Biochim. Biophys. Acta, 870, 58, 10.1016/0167-4838(86)90008-7

Rojas, 1990, Calcium-activated endonexin II forms calcium channels across acidic phospholipid bilayer membranes, J. Biol. Chem., 265, 21207, 10.1016/S0021-9258(17)45347-6

Tait, 1989, Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family, J. Biol. Chem., 264, 7944, 10.1016/S0021-9258(18)83133-7

Gerke, 1984, Identity of P36k phosphorylated upon rous-sarcoma virus transformation with a protein purified from brush-borders; calcium-dependent binding to non-erythroid spectrin and F-actin, EMBO J., 3, 227, 10.1002/j.1460-2075.1984.tb01789.x

Capila, 1999, Interaction of heparin with annexin V, FEBS Lett., 446, 327, 10.1016/S0014-5793(99)00245-8

Capila, 2001, Annexin V-heparin oligosaccharide complex suggests heparan sulfate-mediated assembly on cell surfaces, Structure, 9, 57, 10.1016/S0969-2126(00)00549-9

Ishitsuka, 1998, Glycosaminoglycan binding properties of annexin IV, V, and VI, J. Biol. Chem., 273, 9935, 10.1074/jbc.273.16.9935

Hileman, 1997, Preparation and structure of heparin lyase-derived heparan sulfate oligosaccharides, Glycobiology, 7, 231, 10.1093/glycob/7.2.231

Pervin, 1995, Preparation and structural characterization of large heparin-derived oligosaccharides, Glycobiology, 5, 83, 10.1093/glycob/5.1.83

Rice, 1989, Study of structurally defined oligosaccharide substrates of heparin and heparan monosulfate lyases, Carbohydr. Res., 190, 219, 10.1016/0008-6215(89)84127-8

Basten, 1992, Biologically active heparin-like fragments with a “non-glycosamino” glycan structure. Part 3: O-alkylated-O-sulphated pentasaccharides, Bioorg. Med. Chem. Lett., 2, 905, 10.1016/S0960-894X(00)80585-5

Petitou, 2001, Experimental proof for the structure of a thrombin-inhibiting heparin molecule, Chemistry, 7, 858, 10.1002/1521-3765(20010216)7:4<858::AID-CHEM858>3.0.CO;2-N

Zhu, 2000, A new set of orthogonal-protecting groups for oligosaccharide synthesis on a polymeric support, Tetrahedron Asymmetry, 11, 199, 10.1016/S0957-4166(99)00569-8

Kovensky, 2002, Further evidence for the critical role of a non-chair conformation of L-iduronic acid in the activation of antithrombin, Eur. J. Org. Chem., 2002, 3595, 10.1002/1099-0690(200211)2002:21<3595::AID-EJOC3595>3.0.CO;2-F

Haller, 2001, Towards a modular approach for heparin synthesis, J. Chem. Soc. Perkin Trans., 1, 814, 10.1039/b009845k

Jaurand, 1994, Synthesis of the basic disaccharide unit of heparin, Carbohydr. Res., 255, 295, 10.1016/S0008-6215(00)90986-8

Tabeur, 1999, Oligosaccharides corresponding to the regular sequence of heparin: chemical synthesis and interaction with FGF-2, Bioorg. Med. Chem., 7, 2003, 10.1016/S0968-0896(99)00113-3

Lucas, 2004, Synthesis of glycosaminoglycan oligosaccharides. An unexpected inhibitory effect of a remote N-acetyl group upon trichloroacetimidate-mediated couplings, Eur. J. Org. Chem., 2004, 2107, 10.1002/ejoc.200300791

Haller, 2002, Selectively protected disaccharide building blocks for modular synthesis of heparin fragments: part 2, Eur. J. Org. Chem., 2002, 2033, 10.1002/1099-0690(200207)2002:13<2033::AID-EJOC2033>3.0.CO;2-W

Kovensky, 1999, A synthetic heparan sulfate pentasaccharide, exclusively containing L-iduronic acid, displays higher affinity for FGF-2 than its D-glucuronic acid-containing isomers, Bioorg. Med. Chem., 7, 1567, 10.1016/S0968-0896(99)00106-6

Jacquinet, 1984, Carbohydr. Res., 130, 221, 10.1016/0008-6215(84)85281-7

Vlahov, 1995, Regioselective synthesis of derivatives of L-idopyranuronic acid: a key constituent of glycosaminoglycans, Tetrahedron Lett., 36, 8379, 10.1016/0040-4039(95)01810-5

Bazin, 1997, Regio- and stereoselective conversion of [delta]4-uronic acids to L-ido and D-glucopyranosiduronic acids, Tetrahedron Lett., 38, 923, 10.1016/S0040-4039(96)02514-2

Dromowicz, 1998, A convenient synthesis of L-idose, Carbohydr. Res., 308, 169, 10.1016/S0008-6215(98)00048-2

Hinou, 1999, Novel synthesis of L iduronic acid using trehalose as the disaccharidic starting material, Tetrahedron Lett., 40, 1501, 10.1016/S0040-4039(98)02662-8

Medakovic, 1994, An efficient synthesis of methyl 1,2,3,4-tetra-O-acetyl-beta- L- idopyranuronate, Carbohydr. Res., 253, 299, 10.1016/0008-6215(94)80076-6

Chiba, 1986, Application of a radical reaction to the synthesis of L- iduronic acid-derivatives from D-glucuronic acid analogs, Carbohydr. Res., 151, 379, 10.1016/S0008-6215(00)90357-4

Baggett, 1984, Re-examination of the acid-hydrolysis of 5,6-anhydro-1,2-O-isopropylidene-beta-L-idofuranose, Carbohydr. Res., 127, 149, 10.1016/0008-6215(84)85115-0

Macher, 1980, Synthesis of L-idofuranurono-6,3-lactone and its derivatives via hexodialdodifuranoses, Carbohydr. Res., 80, 45, 10.1016/S0008-6215(00)85313-6

Adinolfi, 1999, Intramolecular Tishchenko reactions of protected hexos-5-uloses: a novel and efficient synthesis of L-idose and L-altrose, Synlett, 3, 336, 10.1055/s-1999-3156

Rochepeau-Jobron, 1997, Diastereoselective hydroboration of substituted exo-glucals revisited. A convenient route for the preparation of L-iduronic acid derivatives, Carbohydr. Res., 303, 395, 10.1016/S0008-6215(97)00149-3

Yu, 2004, Novel efficient routes to heparin monosaccharides and disaccharides achieved via regio- and stereoselective glycosidation, Org. Lett., 6, 723, 10.1021/ol036390m

Lee, 2004, From D-glucose to biologically potent L-hexose derivatives: synthesis of alpha-L-iduronidase fluorogenic detector and the disaccharide moieties of bleomycin A(2) and heparan sulfate, Chemistry, 10, 399, 10.1002/chem.200305096

Ke, 2003, A short route to L-iduronic acid building blocks for the syntheses of heparin-like disaccharides, Tetrahedron Lett., 44, 7767, 10.1016/j.tetlet.2003.08.092

Dilhas, 2003, Efficient selective preparation of methyl-1,2,4-tri-O-acetyl-3-O-benzyl-beta-L-idopyranuronate from methyl 3-O-benzyl-L-iduronate, Carbohydr. Res., 338, 681, 10.1016/S0008-6215(02)00525-6

Schell, 2001, Synthesis and transformations of D-glucuronic and L-iduronic acid glycals, Tetrahedron Lett., 42, 3811, 10.1016/S0040-4039(01)00607-4

Das, 2001, Synthesis of conformationally locked L-iduronic acid derivatives: direct evidence for a critical role of the skew-boat 2S0 conformer in the activation of antithrombin by heparin, Chemistry, 7, 4821, 10.1002/1521-3765(20011119)7:22<4821::AID-CHEM4821>3.0.CO;2-N

Lubineau, 2000, New accesses to L-iduronyl synthons, Tetrahedron Lett., 41, 307, 10.1016/S0040-4039(99)02080-8

Ojeda, 1999, A new route to L-iduronate building-blocks for the synthesis of heparin-like oligosaccharides, Synlett, 1999, 1316, 10.1055/s-1999-2810

Orgueira, 2003, Modular synthesis of heparin oligosaccharides, Chemistry, 9, 140, 10.1002/chem.200390009

Lohman, 2003, Synthesis of iduronic acid building blocks for the modular assembly of glycosaminoglycans, J. Org. Chem., 68, 7559, 10.1021/jo0340760

Prabhu, 2003, New set of orthogonal protecting groups for the modular synthesis of heparan sulfate fragments, Org. Lett., 5, 4975, 10.1021/ol0359261

Hung, 2001, 1,6-anhydro-beta-L-hexopyranoses as potent synthons in the synthesis of the disaccharide units of bleomycin A(2) and heparin, J. Am. Chem. Soc., 123, 3153, 10.1021/ja003508a

Hung, 2000, Novel synthesis of 1,2: 3,5-di-O-isopropylidene-beta-L-idofuranoside and its derivatives at C-6, Tetrahedron Lett., 41, 77, 10.1016/S0040-4039(99)02004-3

La Ferla, 1999, Synthesis of disaccharidic sub-units of a new series of heparin related oligosaccharides, Tetrahedron, 55, 9867, 10.1016/S0040-4020(99)00526-8

Orgueira, 2002, Conformational locking of the glycosyl acceptor for stereocontrol in the key step in the synthesis of heparin, Angew. Chem. Int. Ed. Engl., 41, 2128, 10.1002/1521-3773(20020617)41:12<2128::AID-ANIE2128>3.0.CO;2-V

de Paz, 2003, Some key experimental features of a modular synthesis of heparin-like oligosaccharides, Eur. J. Org. Chem., 2003, 3308, 10.1002/ejoc.200300210

Seeberger, 2000, Solid-phase oligosaccharide synthesis and combinatorial carbohydrate libraries, Chem. Rev., 100, 4349, 10.1021/cr9903104

Ojeda, 2003, Synthesis of heparin-like oligosaccharides on a soluble polymer support, Chem. Commun., 2486, 10.1039/B307259B

Dreef-Tromp, 1997, Polymer-supported solution synthesis of heparan sulphate-like oligomers, Bioorg. Med. Chem. Lett., 7, 1175, 10.1016/S0960-894X(97)00183-2

Ojeda, 2004, Synthesis of heparin-like oligosaccharides on polymer supports, Glycoconj. J., 21, 179, 10.1023/B:GLYC.0000045091.18392.a8

Petitou, 1986, Carbohydr. Res., 147, 221, 10.1016/S0008-6215(00)90633-5

Sinay, 1984, Total synthesis of a heparin pentasaccharide fragment having high affinity for antithrombin III, Carbohydr. Res., 132, C5, 10.1016/0008-6215(84)85236-2

Petitou, 1987, Synthesis of heparin fragments: a methyl [alpha]-pentaoside with high affinity for antithrombin III, Carbohydr. Res., 167, 67, 10.1016/0008-6215(87)80268-9

Petitou, 1991, A new, highly potent, heparin-like pentasaccharide fragment containing a glucose residue instead of a glucosamine, Bioorg. Med. Chem. Lett., 1, 95, 10.1016/S0960-894X(00)80238-3

van Boeckel, 1988, Synthesis of a potent antithrombin activating pentasaccharide: a new heparin-like fragment containing two 3-O-sulfated glucosamines, Tetrahedron Lett., 29, 803, 10.1016/S0040-4039(00)80214-2

Jaurand, 1992, Biologically-active heparin-like fragments with a non-glycosamino glycan structure. Part 1: a pentasaccharide containing a 3-ortho-methyl iduronic acid unit, Bioorg. Med. Chem. Lett., 2, 897, 10.1016/S0960-894X(00)80583-1

Basten, 1992, Biologically-active heparin-like fragments with a non-glycosamino glycan structure. Part 2: a tetra-ortho-methylated pentasaccharide with high-affinity for antithrombin-III, Bioorg. Med. Chem. Lett., 2, 901, 10.1016/S0960-894X(00)80584-3

Nukada, 1991, Syntheses of larger modified oligosaccharides containing opened carbohydrate fragments, Synlett, 1991, 365, 10.1055/s-1991-34742

Lucas, 1993, A short synthetic route towards a biologically-active heparin-like pentasaccharide with a pseudo-alternating sequence, Angew. Chem. Int. Ed. Engl., 32, 434, 10.1002/anie.199304341

Westerduin, 1994, Feasible synthesis and biological properties of six ‘non-glycosamino’ glycan analogs of the antithrombin III binding heparin pentasaccharide, Bioorg. Med. Chem., 2, 1267, 10.1016/S0968-0896(00)82078-7

Sakairi, 1996, Synthesis of a conformationally constrained heparin-like pentasaccharide, Chemistry (Easton), 2, 1007

Petitou, 1998, Introducing a C-interglycosidic bond in a biologically active pentasaccharide hardly affects its biological properties, Bioorg. Med. Chem., 6, 1509, 10.1016/S0968-0896(98)00094-7

Helmboldt, 1997, Synthesis and biological activity of a new anti-factor Xa pentasaccharide with a C-interglycosidic bond, Bioorg. Med. Chem. Lett., 7, 1507, 10.1016/S0960-894X(97)00252-7

Lei, 1998, Synthesis of a 3-deoxy-L-iduronic acid containing heparin pentasaccharide to probe the conformation of the antithrombin III binding sequence, Bioorg. Med. Chem., 6, 1337, 10.1016/S0968-0896(98)00127-8

Das, 2001, Synthesis of conformationally locked carbohydrates: a skew-boat conformation of L-iduronic acid governs the antithrombotic activity of heparin, Angew. Chem. Int. Ed. Engl., 40, 1670, 10.1002/1521-3773(20010504)40:9<1670::AID-ANIE16700>3.0.CO;2-Q

Sisu, 2003, Synthesis of new conformationally constrained pentasaccharides as molecular probes to investigate the biological activity of heparin, Biochimie, 85, 91, 10.1016/S0300-9084(03)00054-3

Codee, 2002, Probing the heparin-antithrombin III interaction using synthetic pentasaccharides bearing positively charged groups, Eur. J. Org. Chem., 2002, 3954, 10.1002/1099-0690(200212)2002:23<3954::AID-EJOC3954>3.0.CO;2-2

Westerduin, 1996, Synthesis of tailor-made glycoconjugates showing ATIII-mediated inhibition of blood coagulation factors Xa and thrombin, Angew. Chem. Int. Ed. Engl., 35, 331, 10.1002/anie.199603311

Basten, 1998, In vitro evaluation of synthetic heparin-like conjugates comprising different thrombin binding domains, Bioorg. Med. Chem. Lett., 8, 1201, 10.1016/S0960-894X(98)00196-6

Buijsman, 1996, Synthesis of a pentasaccharide-oligonucleotide conjugate: a novel antithrombotic agent, Chemistry (Easton), 2, 1572

Buijsman, 1999, Design and synthesis of a novel synthetic NAPAP-pentasaccharide conjugate displaying a dual antithrombotic action, Bioorg. Med. Chem. Lett., 9, 2013, 10.1016/S0960-894X(99)00320-0

Petitou, 1998, First synthetic carbohydrates with the full anticoagulant properties of heparin, Angew. Chem. Int. Ed. Engl., 37, 3009, 10.1002/(SICI)1521-3773(19981116)37:21<3009::AID-ANIE3009>3.0.CO;2-F

Duchaussoy, P., Jaurand, G., Driguez, P.A., Lederman, I., Gourvenec, F., Strassel, J.M., Sizun, P., Petitou, M., and Herbert, J.M. (1999). Design and synthesis of heparin mimetics able to inhibit thrombin. Part 1: identification of a hexasaccharide sequence able to inhibit thrombin and suitable for ‘polymerisation.’ Carbohydr. Res. 317, 63–84.

Duchaussoy, 1999, Assessment through chemical synthesis of the size of the heparin sequence involved in thrombin inhibition, Carbohydr. Res., 317, 85, 10.1016/S0008-6215(99)00068-3

Dreef-Tromp, 1998, Biological properties of synthetic glycoconjugate mimics of heparin comprising different molecular spacers, Bioorg. Med. Chem. Lett., 8, 2081, 10.1016/S0960-894X(98)00382-5

Petitou, 1999, New synthetic heparin mimetics able to inhibit thrombin and factor Xa, Bioorg. Med. Chem. Lett., 9, 1155, 10.1016/S0960-894X(99)00155-9

Petitou, 1999, Synthetic oligosaccharides having various functional domains: potent and potentially safe heparin mimetics, Bioorg. Med. Chem. Lett., 9, 1161, 10.1016/S0960-894X(99)00156-0

Driguez, 1999, Synthetic carbohydrate derivatives as low sulfated heparin mimetics, J. Org. Chem., 64, 9512, 10.1021/jo991152j

Nilsson, 1993, Synthesis of the methyl glycosides of a tri- and a tetra-saccharide related to heparin and heparan sulfate, Carbohydr. Res., 246, 161, 10.1016/0008-6215(93)84030-A

Westman, 1995, Synthesis and fibroblast growth-factor binding of oligosaccharides related to heparin and heparan-sulfate, J. Carbohydr. Chem., 14, 95, 10.1080/07328309508006439

Kovensky, 1996, Binding of heparan sulfate to fibroblast growth factor-2 total synthesis of a putative pentasaccharide binding site, Tetrahedron Asymmetry, 7, 3119, 10.1016/0957-4166(96)00412-0

Poletti, 2001, A rational approach to heparin-related fragments. Synthesis of differently sulfated tetrasaccharides as potential ligands for fibroblast growth factors, Eur. J. Org. Chem., 2001, 2727, 10.1002/1099-0690(200107)2001:14<2727::AID-EJOC2727>3.0.CO;2-8

de Paz, 2001, The activation of fibroblast growth factors by heparin: synthesis, structure, and biological activity of heparin-like oligosaccharides, ChemBioChem, 2, 673, 10.1002/1439-7633(20010903)2:9<673::AID-CBIC673>3.0.CO;2-7

Ojeda, 2002, The activation of fibroblast growth factors by heparin: synthesis and structural study of rationally modified heparin- like oligosaccharides, Can. J. Chem., 80, 917, 10.1139/v02-023

Lucas, 2003, Synthesis and structural study of two new heparin-like hexasaccharides, Org. Biomol. Chem., 1, 2253, 10.1039/B303115B

Casu, 2001, Structure and biological interactions of heparin and heparan sulfate, Adv. Carbohydr. Chem. Biochem., 57, 159, 10.1016/S0065-2318(01)57017-1

Spivakkroizman, 1994, Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell-proliferation, Cell, 79, 1015, 10.1016/0092-8674(94)90032-9

Kan, 1996, Divalent cations cooperate with heparin or heparan sulfate to regulate assembly of the fibroblast growth factor receptor complex, Mol. Biol. Cell, 7, 1074

Bedsted, 2003, Heparin and calcium ions dramatically enhance antithrombin reactivity with factor IXa by generating new interaction exosites, Biochemistry, 42, 8143, 10.1021/bi034363y

O’Brien, 2003, Glycosaminoglycans bind factor Xa in a Ca2+-dependent fashion and modulate its catalytic activity, Biochemistry, 42, 13091, 10.1021/bi0345586

Angulo, 2000, Interaction of heparin with Ca2+: a model study with a synthetic heparin-like hexasaccharide, Isr. J. Chem., 40, 289, 10.1560/9REV-7CHB-BB93-09UV

Chevalier, 2002, The heparin-Ca2+ interaction: structure of the Ca2+ binding site, Eur. J. Org. Chem., 2002, 2367, 10.1002/1099-0690(200207)2002:14<2367::AID-EJOC2367>3.0.CO;2-K

Chevalier, 2004, The heparin-Ca2+ interaction: the influence of the O-sulfation pattern on binding, Carbohydr. Res., 339, 975, 10.1016/j.carres.2003.12.023

Angulo, 2004, The activation of fibroblast growth factors (FGFs) by glycosaminoglycans: influence of the sulfation pattern on the biological activity of FGF-1, ChemBioChem, 5, 55, 10.1002/cbic.200300696

Liu, 2002, Cell surface heparan sulfate and its roles in assisting viral infectious, Med. Res. Rev., 22, 1, 10.1002/med.1026

Liu, 2002, Characterization of a heparan sulfate octasaccharide that binds to herpes simplex virus type 1 glycoprotein D, J. Biol. Chem., 277, 33456, 10.1074/jbc.M202034200

Shukla, 2004, Role of 3-O-sulfated heparan sulfate in herpes simplex virus type-1 entry and spread, Invest. Ophthalmol. Vis. Sci., 45, U595

Tiwari, 2004, A role for 3-O-sulfated heparan sulfate in cell fusion induced by herpes simplex virus type 1, J. Gen. Virol., 85, 805, 10.1099/vir.0.19641-0

Lohman, 2004, A stereochemical surprise at the late stage of the synthesis of fully N-differentiated heparin oligosaccharides containing amino, acetamido, and N-sulfonate groups, J. Org. Chem., 69, 4081, 10.1021/jo035732z

Sobel, 2001, Heparin modulates integrin function in human platelets, J. Vasc. Surg., 33, 587, 10.1067/mva.2001.112696

Koshida, 2001, Synthesis of oligomeric assemblies of a platelet-binding key disaccharide in heparin and their biological activities, Tetrahedron Lett., 42, 1289, 10.1016/S0040-4039(00)01826-8

Koshida, 2001, Synthesis, designed assembly, and biological activity of heparin fragments responsible for binding interaction to platelets, Trends Glycosci. Glycotechnol., 13, 209, 10.4052/tigg.13.209